High Tower Advisors, LLC Oyster Point Pharma, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$10.17 - $18.96 $110,975 - $206,891	-10,912 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.67 - $18.07 $127,343 - $197,179	10,912 New	10,912 $129,000
Q2 2021 Aug 06, 2021	SELL	$16.25 - $21.51 $166,400 - $220,262	-10,240 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$17.92 - $25.86 $381,337 - $550,300	-21,280 Reduced 67.51%	10,240 $187,000
Q4 2020 Feb 10, 2021	BUY	$18.13 - $25.18 $571,457 - $793,673	31,520 New	31,520 $593,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.